172 related articles for article (PubMed ID: 30535754)
41. Coronary heart disease risk equivalence in diabetes and arterial diseases characterized by endothelial function and endothelial progenitor cell.
Liao YF; Feng Y; Chen LL; Zeng TS; Yu F; Hu LJ
J Diabetes Complications; 2014; 28(2):214-8. PubMed ID: 24332936
[TBL] [Abstract][Full Text] [Related]
42. Differential expression of circulating vascular cell adhesion molecule-1 in subjects with coronary artery disease and cardiac syndrome X without known diabetes mellitus.
Liang KW; Sheu WH; Lee WJ; Lee WL; Fu CP; Wang JS
Biomarkers; 2017 Dec; 22(8):798-804. PubMed ID: 28675064
[TBL] [Abstract][Full Text] [Related]
43. The link between circulating markers of endothelial function and proteinuria in patients with primary glomerulonephritis.
Mackinnon B; Deighan CJ; Norrie J; Boulton-Jones JM; Sattar N; Fox JG
Clin Nephrol; 2005 Mar; 63(3):173-80. PubMed ID: 15786817
[TBL] [Abstract][Full Text] [Related]
44. [Soluble cell adhesion molecules in chronic renal graft rejection].
Boratyńska M
Pol Arch Med Wewn; 1998 Nov; 100(5):410-8. PubMed ID: 10410574
[TBL] [Abstract][Full Text] [Related]
45. Circulating markers of inflammation and endothelial function, and their relationship to diabetic retinopathy.
Sasongko MB; Wong TY; Jenkins AJ; Nguyen TT; Shaw JE; Wang JJ
Diabet Med; 2015 May; 32(5):686-91. PubMed ID: 25407692
[TBL] [Abstract][Full Text] [Related]
46. Serum levels of adhesion molecules ICAM-1 and VCAM-1 and tissue inhibitor of metalloproteinases, TIMP-1, are elevated in patients with autoimmune thyroid disorders: relevance to vascular inflammation.
Jublanc C; Beaudeux JL; Aubart F; Raphael M; Chadarevian R; Chapman MJ; Bonnefont-Rousselot D; Bruckert E
Nutr Metab Cardiovasc Dis; 2011 Oct; 21(10):817-22. PubMed ID: 20685094
[TBL] [Abstract][Full Text] [Related]
47. Expression of Vascular Cell Adhesion Molecule-1 in Peripheral Artery Disease is Enriched in Patients with Advanced Kidney Disease.
Lee PT; Liao IC; Lee CH; Hsu LW; Liu PY
Acta Cardiol Sin; 2021 Nov; 37(6):591-599. PubMed ID: 34812232
[TBL] [Abstract][Full Text] [Related]
48. Circulating cytokines present in the serum of peripheral arterial disease patients induce endothelial dysfunction.
Botti C; Maione C; Dogliotti G; Russo P; Signoriello G; Molinari AM; Corsi MM; Sica V; Cobellis G
J Biol Regul Homeost Agents; 2012; 26(1):67-79. PubMed ID: 22475098
[TBL] [Abstract][Full Text] [Related]
49. Soluble Vascular Cell Adhesion Molecule-1 (VCAM-1) as a Biomarker in the Mouse Model of Experimental Autoimmune Myocarditis (EAM).
Grabmaier U; Kania G; Kreiner J; Grabmeier J; Uhl A; Huber BC; Lackermair K; Herbach N; Todica A; Eriksson U; Weckbach LT; Brunner S
PLoS One; 2016; 11(8):e0158299. PubMed ID: 27501319
[TBL] [Abstract][Full Text] [Related]
50. Expression of VCAM-1 in rabbit iliac arteries is associated with vasodilator dysfunction of regenerated endothelium following balloon injury.
Krejcy K; Schwarzacher S; Ferber W; Plesch C; Cybulsky MI; Weidinger FF
Atherosclerosis; 1996 Apr; 122(1):59-67. PubMed ID: 8724112
[TBL] [Abstract][Full Text] [Related]
51. Folic acid reduces adhesion molecules VCAM-1 expession in aortic of rats with hyperhomocysteinemia.
Li M; Chen J; Li YS; Feng YB; Gu X; Shi CZ
Int J Cardiol; 2006 Jan; 106(2):285-8. PubMed ID: 16183151
[TBL] [Abstract][Full Text] [Related]
52. Posttraumatic stress disorder onset and inflammatory and endothelial function biomarkers in women.
Sumner JA; Chen Q; Roberts AL; Winning A; Rimm EB; Gilsanz P; Glymour MM; Tworoger SS; Koenen KC; Kubzansky LD
Brain Behav Immun; 2018 Mar; 69():203-209. PubMed ID: 29157934
[TBL] [Abstract][Full Text] [Related]
53. C-reactive protein and soluble vascular cell adhesion molecule-1 are associated with elevated urinary albumin excretion but do not explain its link with cardiovascular risk.
Jager A; van Hinsbergh VW; Kostense PJ; Emeis JJ; Nijpels G; Dekker JM; Heine RJ; Bouter LM; Stehouwer CD
Arterioscler Thromb Vasc Biol; 2002 Apr; 22(4):593-8. PubMed ID: 11950696
[TBL] [Abstract][Full Text] [Related]
54. Elevation of a novel angiogenic factor, leucine-rich-α2-glycoprotein (LRG1), is associated with arterial stiffness, endothelial dysfunction, and peripheral arterial disease in patients with type 2 diabetes.
Pek SL; Tavintharan S; Wang X; Lim SC; Woon K; Yeoh LY; Ng X; Liu J; Sum CF
J Clin Endocrinol Metab; 2015 Apr; 100(4):1586-93. PubMed ID: 25636050
[TBL] [Abstract][Full Text] [Related]
55. Microalbuminuria and early endothelial activation in essential hypertension.
Cottone S; Mulè G; Nardi E; Lorito MC; Guarneri M; Arsena R; Briolotta C; Vadalà A; Cerasola G
J Hum Hypertens; 2007 Feb; 21(2):167-72. PubMed ID: 17051235
[TBL] [Abstract][Full Text] [Related]
56. Correlation between circulating adhesion molecules and resistin levels in hypertensive type-2 diabetic patients.
Lozano-Nuevo JJ; Estrada-Garcia T; Vargas-Robles H; Escalante-Acosta BA; Rubio-Guerra AF
Inflamm Allergy Drug Targets; 2011 Feb; 10(1):27-31. PubMed ID: 21184654
[TBL] [Abstract][Full Text] [Related]
57. Endothelial progenitor cells as a biological marker of peripheral artery disease.
Bitterli L; Afan S; Bühler S; DiSanto S; Zwahlen M; Schmidlin K; Yang Z; Baumgartner I; Diehm N; Kalka C
Vasc Med; 2016 Feb; 21(1):3-11. PubMed ID: 26511986
[TBL] [Abstract][Full Text] [Related]
58. Association of osteoprotegerin with peripheral artery disease in patients with type 2 diabetes.
Esteghamati A; Aflatoonian M; Rad MV; Mazaheri T; Mousavizadeh M; Nakhjavani M; Noshad S
Arch Cardiovasc Dis; 2015; 108(8-9):412-9. PubMed ID: 26184866
[TBL] [Abstract][Full Text] [Related]
59. Evaluation and analysis of plasma soluble adhesion molecules in patients with coronary ectasia and atherosclerotic coronary artery disease.
Soto ME; Reyes-Villatoro MA; Márquez R; Cardoso G; Posadas-Sánchez R; Juárez-Orozco LE
Arch Med Res; 2014 Aug; 45(6):478-83. PubMed ID: 25034460
[TBL] [Abstract][Full Text] [Related]
60. Biomarker profiles of endothelial activation and dysfunction in rare systemic autoimmune diseases: implications for cardiovascular risk.
Wienke J; Mertens JS; Garcia S; Lim J; Wijngaarde CA; Yeo JG; Meyer A; van den Hoogen LL; Tekstra J; Hoogendijk JE; Otten HG; Fritsch-Stork RDE; de Jager W; Seyger MMB; Thurlings RM; de Jong EMGJ; van der Kooi AJ; van der Pol WL; ; Arkachaisri T; Radstake TRDJ; van Royen-Kerkhof A; van Wijk F
Rheumatology (Oxford); 2021 Feb; 60(2):785-801. PubMed ID: 32810267
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
